Table 7. Association between TUBB3 and response to different chemotherapy regimen.
Therapy | RR% | P | OS (month) | P | PFS (month) | P | |
---|---|---|---|---|---|---|---|
TUBB3≤2 | Paclitaxel | 11/18(61.1%) | 7.9 | 13.8 | |||
Ciplatin | 5/16(31.3%) | 0.196 | 2.9 | 0.196 | 9.2 | 0.324 | |
TUBB3>2 | Paclitaxel | 6/18(33.3%) | 3.2 | 6.6 | |||
Cisplatin | 2/5(40%) | 1.0 | 6.3 | 0.509 | 0.469 |